Biodesix Closes on $20M Series D Round
July 15, 2011
Biodesix Closes on $20M Series D Round
The funds will go toward commercialization of its VeriStrat test for non-small cell lung cancer and to support collaborations with biotechnology and pharmaceutical firms to develop companion diagnostics.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Interleukin Genetics Raises $12M in Private Placement
May 20, 2013 / GenomeWeb Daily News - GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor - CombiMatrix to Raise $2.4M in Private Placement
May 6, 2013 / GenomeWeb Daily News - SQI Closes $3.8M Private Placement
May 3, 2013 / GenomeWeb Daily News - SQI Diagnostics Looks to Raise $3.7M in Private Placement
April 30, 2013 / GenomeWeb Daily News